Lupkynis (voclosporin) — United Healthcare
active lupus nephritis
Initial criteria
- Diagnosis of active lupus nephritis
- Prescribed in combination with a background immunosuppressive therapy regimen (e.g., mycophenolate mofetil and corticosteroids)
- Patient is not receiving Lupkynis in combination with cyclophosphamide
Reauthorization criteria
- Documentation of positive clinical response to Lupkynis therapy
- Prescribed in combination with a background immunosuppressive therapy regimen (e.g., mycophenolate mofetil and corticosteroids)
- Patient is not receiving Lupkynis in combination with cyclophosphamide
Approval duration
12 months